PF-03882845
- Generic Name
- PF-03882845
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H22ClN3O2
- CAS Number
- 1023650-66-9
- Unique Ingredient Identifier
- 34ZKU73FU3
- Background
PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.
- Associated Conditions
- -
- Associated Therapies
- -
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
Phase 1
Terminated
- Conditions
- Interventions
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2013-10-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 6
- Registration Number
- NCT01488877
- Locations
- 🇺🇸
Pfizer Investigational Site, New York, New York, United States
A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption
- First Posted Date
- 2011-06-06
- Last Posted Date
- 2011-06-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT01366287
- Locations
- 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath